| Literature DB >> 24333171 |
Shino Kondoh1, Kazuki Inoue2, Katsuhide Igarashi3, Hiroe Sugizaki4, Yuko Shirode-Fukuda1, Erina Inoue1, Taiyong Yu5, Jun K Takeuchi6, Jun Kanno3, Lynda F Bonewald7, Yuuki Imai8.
Abstract
Estrogens are well known steroid hormones necessary to maintain bone health. In addition, mechanical loading, in which estrogen signaling may intersect with the Wnt/β-catenin pathway, is essential for bone maintenance. As osteocytes are known as the major mechanosensory cells embedded in mineralized bone matrix, osteocyte ERα deletion mice (ERα(ΔOcy/ΔOcy)) were generated by mating ERα floxed mice with Dmp1-Cre mice to determine the role of ERα in osteocytes. Trabecular bone mineral density of female, but not male ERα(ΔOcy/ΔOcy) mice was significantly decreased. Bone formation parameters in ERα(ΔOcy/ΔOcy) were significantly decreased while osteoclast parameters were unchanged. This suggests that ERα in osteocytes exerts osteoprotective function by positively controlling bone formation. To identify potential targets of ERα, gene array analysis of Dmp1-GFP osteocytes sorted by FACS from ERα(ΔOcy/ΔOcy) and control mice was performed. Gene expression microarray followed by gene ontology analyses revealed that osteocytes from ERα(ΔOcy/ΔOcy) highly expressed genes categorized in 'Secreted' when compared to control osteocytes. Among them, expression of Mdk and Sostdc1, both of which are Wnt inhibitors, was significantly increased without alteration of expression of the mature osteocyte markers such as Sost and β-catenin. Moreover, hindlimb suspension experiments showed that trabecular bone loss due to unloading was greater in ERα(ΔOcy/ΔOcy) mice without cortical bone loss. These data suggest that ERα in osteocytes has osteoprotective functions in trabecular bone formation through regulating expression of Wnt antagonists, but conversely plays a negative role in cortical bone loss due to unloading. Published by Elsevier Inc.Entities:
Keywords: Bone formation; Estrogen; Estrogen receptor α; Osteocyte; Wnt signaling
Mesh:
Substances:
Year: 2013 PMID: 24333171 PMCID: PMC3944732 DOI: 10.1016/j.bone.2013.12.005
Source DB: PubMed Journal: Bone ISSN: 1873-2763 Impact factor: 4.398